Trialists should tell participants results, but how?
The Lancet
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001675:Bioethics; D001943:Breast Neoplasms / Q000188:drug therapy; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic / Q000941:ethics*; D003142:Communication; D000077143:Docetaxel; D005260:Female; D006801:Humans; D043823:Taxoids / Q000627:therapeutic use; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel